NCT02283372View on ClinicalTrials.gov

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

May 14, 2018

Study Completion Date

April 18, 2019

Conditions

Pancreatic Cancer

Interventions

DRUG

nab-Paclitaxel

DRUG

Gemcitabine

RADIATION

Intensity modulated radiation

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02283372 - Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter